Cite
HARVARD Citation
Galli, L. et al. (n.d.). Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial. Journal of antimicrobial chemotherapy. pp. 1637-1642. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Galli, L. et al. (n.d.). Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial. Journal of antimicrobial chemotherapy. pp. 1637-1642. [Online].